☰

Shulian Shang, Ph.D. - Publications

Affiliations: 
2012 Environmental Health Science New York University, New York, NY, United States 
Area:
Biostatistics Biology
Tree Info Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Hanniford D, Zhong J, Koetz L, Gaziel-Sovran A, Lackaye DJ, Shang S, Pavlick A, Shapiro RL, Berman RS, Darvishian F, Shao Y, Osman I, Hernando E. A miRNA-based signature detected in primary melanoma tissue predicts development of brain metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26089374 DOI: 10.1158/1078-0432.Ccr-14-2566  0.514
2015 Shao Y, Shang S, Wang S. On the safety margin of using simplified human head models for local SAR simulations of B1-shimming at 7 Tesla. Magnetic Resonance Imaging. 33: 779-86. PMID 25865823 DOI: 10.1016/j.mri.2015.04.002  0.387
2013 Rendleman J, Shang S, Dominianni C, Shields JF, Scanlon P, Adaniel C, Desrichard A, Ma M, Shapiro R, Berman R, Pavlick A, Polsky D, Shao Y, Osman I, Kirchhoff T. Melanoma risk loci as determinants of melanoma recurrence and survival. Journal of Translational Medicine. 11: 279. PMID 24188633 DOI: 10.1186/1479-5876-11-279  0.544
2013 Rendleman J, Shang S, Shields J, Adaniel C, Fleming NH, Shapiro R, Berman RS, Pavlick AC, Shao Y, Osman I, Kirchhoff T. Genetic variation in immunomodulatory genes as markers of melanoma recurrence-free and overall survival. Journal of Clinical Oncology. 31: 9021-9021. DOI: 10.1200/Jco.2013.31.15_Suppl.9021  0.514
2012 Patrawalla P, Kazeros A, Rogers L, Shao Y, Liu M, Fernandez-Beros ME, Shang S, Reibman J. Application of the asthma phenotype algorithm from the Severe Asthma Research Program to an urban population. Plos One. 7: e44540. PMID 23028556 DOI: 10.1371/Journal.Pone.0044540  0.428
2012 Friedman EB, Shang S, de Miera EV, Fog JU, Teilum MW, Ma MW, Berman RS, Shapiro RL, Pavlick AC, Hernando E, Baker A, Shao Y, Osman I. Serum microRNAs as biomarkers for recurrence in melanoma. Journal of Translational Medicine. 10: 155. PMID 22857597 DOI: 10.1186/1479-5876-10-155  0.529
2012 Shang S, Liu M, Shao Y. A Tight Prediction Interval for False Discovery Proportion under Dependence Open Journal of Statistics. 2: 163-171. DOI: 10.4236/Ojs.2012.22018  0.475
2012 Friedman EB, Shang S, Fleming NH, de Miera EV, Hernando E, Shao Y, Osman I. Expression of miR-16 is not a suitable reference for analysis of serum microRNAs in melanoma patients Journal of Biomedical Science and Engineering. 5: 647-651. DOI: 10.4236/Jbise.2012.511080  0.532
2012 Hernando E, Hanniford D, Shang S, Segura MF, Pavlick AC, Berman RS, Shapiro RL, Darvishian F, Osman I, Shao Y. Early alterations of microRNA expression to predict and modulate melanoma metastasis. Journal of Clinical Oncology. 30: 8550-8550. DOI: 10.1200/Jco.2012.30.15_Suppl.8550  0.54
2012 Shang S, Zhou Q, Liu M, Shao Y. Sample Size Calculation for Controlling False Discovery Proportion Journal of Probability and Statistics. 2012: 1-13. DOI: 10.1155/2012/817948  0.449
2012 Rendleman J, Shang S, Brocia C, Ma M, Shapiro R, Berman R, Pavlick A, Shao Y, Osman I, Kirchhoff T. The Melanoma Risk Loci as Determinants of Melanoma Prognosis Annals of Oncology. 23: ix363. DOI: 10.1016/S0923-7534(20)33705-4  0.535
2011 Friedman EB, Shang S, Vega-Saenz de Miera E, Ma MW, Berman RS, Shapiro RL, Pavlick AC, Hernando E, Shao Y, Osman I. An analysis of sera-based microRNAs as biomarkers of recurrence in melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 8513. PMID 28021136 DOI: 10.1200/Jco.2011.29.15_Suppl.8513  0.533
2011 Huynh C, Poliseno L, Segura MF, Medicherla R, Haimovic A, Menendez S, Shang S, Pavlick A, Shao Y, Darvishian F, Boylan JF, Osman I, Hernando E. The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma. Plos One. 6: e25264. PMID 21980408 DOI: 10.1371/Journal.Pone.0025264  0.507
2011 Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford D, Vega-Saenz de Miera E, Rakus JF, Dankert JF, Shang S, Kerbel RS, Bhardwaj N, Shao Y, Darvishian F, Zavadil J, Erlebacher A, et al. miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell. 20: 104-18. PMID 21741600 DOI: 10.1016/J.Ccr.2011.05.027  0.516
2011 Huynh C, Poliseno L, Segura MF, Medicherla R, Haimovic A, Menendez S, Shang S, Pavlick A, Shao Y, Darvishian F, Boylan JF, Osman I, Hernando E. Correction: The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma Plos One. 6. DOI: 10.1371/Annotation/A89C089F-Ae9D-4453-A314-37Efd5Efb126  0.478
2011 Hanniford D, Shang S, Segura M, Tu T, Ma M, Greenwald H, Pavlick AC, Shapiro RL, Berman RS, Shao Y, Osman I, Hernando E. Abstract LB-340: Early alterations of microRNA expression predict and functionally impact melanoma metastasis Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-340  0.528
Show low-probability matches.